Cover Image
Market Research Report

Bioreactor Market Size By Cell, By Molecule, By Technology, By End-Use Industry Analysis Report, Regional Outlook, Application Development, Price Trend, Competitive Landscape & Forecast, 2017 - 2024

Published by Global Market Insights Inc. Product code 555449
Published Content info 100 Pages
Delivery time: 1-2 business days
Price
Back to Top
Bioreactor Market Size By Cell, By Molecule, By Technology, By End-Use Industry Analysis Report, Regional Outlook, Application Development, Price Trend, Competitive Landscape & Forecast, 2017 - 2024
Published: May 10, 2017 Content info: 100 Pages
Description

Bioreactors Market to exceed USD 1.9 billion by 2024 as per a new research report.

Rising prevalence of chronic diseases stimulating demand for personalized medicines and orphan drugs will act as primary drivers for bioreactors market. Increasing investment for R&D activities in biologics industry coupled with growing demand for biopharmaceuticals will fuel bioreactors market growth over the forecast period.

Technological advancements such as single-use bioreactor technology and development of personalized medicines involving several clinical trials and bioprocesses will propel market growth. Concerns related to disposables and leachable coupled with low capacity of single-use bioreactors will hinder bioreactor market growth over the coming years.

Bacterial cells market should grow at lucrative rate due to rising demand for advanced antibiotics, increasing prevalence of food borne diseases and growth of food microbiology sector. Rising adoption of immobilized bacterial bioreactors in small manufacturing plant and commercial laboratories will fuel business growth.

Monoclonal antibodies market will witness significant growth during the forecast period due to increasing therapeutic application of monoclonal antibodies in asthma, breast cancers, rheumatoid arthritis, psoriasis, leukemia, chronic gastrointestinal inflammatory disease, and transplant rejection treatment. Monoclonal antibodies possess extended half-life, reduced toxicity and superior specificity thereby increasing demand over the coming years.

Single-use bubble column market will grow considerably over the forecast period owing to rising demand for single-use bubble column reactor in biotechnology industry. Automation, compactness, high mass transfer and heat transfer rates coupled with low operational and maintenance requirement will fuel product demand.

Contract manufacturing organizations (CMO's) market will exhibit lucrative growth over the forecast period due to rising number of contract manufacturing organizations and growing demand for biopharmaceuticals. Rising trend in pharmaceutical industry towards outsourcing clinical trials and other such functions to CMO's to reduce regulatory burden and cost will favor industry growth.

U.S. bioreactors market should grow at a significant CAGR over the forecast period. Increasing investment in R&D pertaining to biopharmaceuticals and growing adoption of single-use products will drive U.S. bioreactors market. Rising demand for personalized medicines and technological advancements in products will positively impact market growth.

High growth of biotechnology industry along with initiation of programs such as 'The National Biotechnology Program' will drive Brazil bioreactors market over the forecast period. Strategic collaboration between pharmaceutical companies and research organizations, universities will favor business growth.

South Africa bioreactors market will be driven by rising prevalence of chronic diseases stimulating demand for personalized medicines, growing adoption of biopharmaceutical products and increased investment for healthcare infrastructure development. Favorable government policies to support growth of biotechnology industry will favor regional growth.

Few notable industry players include GE Healthcare, Sartorius, Thermo Fisher Scientific, Eppendorf, and Merck Millipore. Strategic alliances, merger and acquisitions are key strategies followed by market players to strengthen their product portfolio and position in the market.

Table of Contents
Product Code: 141

Table of Contents

Chapter 1. Methodology

  • 1.1. Methodology
    • 1.1.1. Initial data exploration
    • 1.1.2. Statistical model and forecast
    • 1.1.3. Industry insights and validation
    • 1.1.4. Market definition and forecast parameters
  • 1.2. Data sources
    • 1.2.1. Primary
    • 1.2.2. Secondary

Chapter 2. Executive Summary

  • 2.1. Bioreactor industry 360 degree synopsis, 2013 - 2024
    • 2.1.1. Business trends
    • 2.1.2. Product trends
    • 2.1.3. Technology trends
    • 2.1.4. End use trends
    • 2.1.5. Regional trends

Chapter 3. Bioreactor Industry Insights

  • 3.1. Industry segmentation
  • 3.2. Industry landscape, 2013 - 2024
  • 3.3. Industry ecosystem analysis
    • 3.3.1. Distribution channel analysis
    • 3.3.2. Vendor matrix
  • 3.4. Industry impact forces
    • 3.4.1. Growth drivers
    • 3.4.1.1. Growing biopharmaceuticals and biologics industry
    • 3.4.1.2. Technological advancements in bioreactor
    • 3.4.1.3. Growing orphan drugs developments
    • 3.4.1.4. Increasing demand for personalized medicines
    • 3.4.2. Industry pitfalls & challenges
    • 3.4.2.1. Low capacity of single use bioreactor
    • 3.4.2.2. Concerns regarding extractables
  • 3.5. Regulatory landscape
    • 3.5.1. U.S.
    • 3.5.2. Canada
    • 3.5.3. Germany
    • 3.5.4. UK
    • 3.5.5. China
  • 3.6. Outsourcing landscape
  • 3.7. Technology landscape
    • 3.7.1. U.S.
    • 3.7.2. Europe
  • 3.8. Growth potential analysis
    • 3.8.1. By Molecule
    • 3.8.2. By Technology
  • 3.9. Porter's analysis
  • 3.10. Bioreactor competitive landscape, 2016
    • 3.10.1. Business overview
    • 3.10.2. Revenue analysis
    • 3.10.3. Product landscape
    • 3.10.4. Strategy dashboard
  • 3.11. PESTEL analysis

Chapter 4. Bioreactor Market, By Cell

  • 4.1. Global bioreactor market share by cell, 2016 & 2024
  • 4.2. Mammalian cells
    • 4.2.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 4.3. Bacterial cells
    • 4.3.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 4.4. Yeast cells
    • 4.4.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 4.5. Other cells
    • 4.5.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)

Chapter 5. Bioreactor Market, By Molecule

  • 5.1. Global bioreactor market share by molecule, 2016 & 2024
  • 5.2. mAbs
    • 5.2.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 5.3. Vaccine
    • 5.3.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 5.4. Recombinant protein
    • 5.4.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 5.5. Stem cell
    • 5.5.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 5.6. Gene therapy
    • 5.6.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 5.7. Other molecules
    • 5.7.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)

Chapter 6. Bioreactor Market, By Technology

  • 6.1. Global bioreactor market share by technology, 2016 & 2024
  • 6.2. Wave-induced motion SUB
    • 6.2.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 6.3. Stirred SUB
    • 6.3.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 6.4. Stirred use bubble column
    • 6.4.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 6.5. Other
    • 6.5.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)

Chapter 7. Bioreactor Market, By End Use

  • 7.1. Global bioreactor market share by end use, 2016 & 2024
  • 7.2. Research and development (R&D)
    • 7.2.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 7.3. Biopharma manufacturers
    • 7.3.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)
  • 7.4. Contract manufacturing organisations (CMOs)
    • 7.4.1. Market estimates and forecast, by region, 2013 - 2024 (USD Million)

Chapter 8. Bioreactor Market, By Region

  • 8.1. Bioreactor market share by region, 2016 & 2024
  • 8.2. North America
    • 8.2.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
    • 8.2.2. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.2.3. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.2.4. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.2.5. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.2.6. U.S.
    • 8.2.6.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.2.6.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.2.6.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.2.6.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.2.7. Canada
    • 8.2.7.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.2.7.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.2.7.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.2.7.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
  • 8.3. Europe
    • 8.3.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
    • 8.3.2. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.3.3. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.3.4. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.3.5. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.3.6. Germany
    • 8.3.6.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.3.6.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.3.6.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.3.6.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.3.7. UK
    • 8.3.7.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.3.7.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.3.7.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.3.7.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.3.8. Spain
    • 8.3.8.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.3.8.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.3.8.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.3.8.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.3.9. Italy
    • 8.3.9.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.3.9.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.3.9.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.3.9.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.3.10. France
    • 8.3.10.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.3.10.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.3.10.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.3.10.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.3.11. Netherlands
    • 8.3.11.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.3.11.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.3.11.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.3.11.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.3.12. Denmark
    • 8.3.12.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.3.12.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.3.12.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.3.12.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
    • 8.4.2. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.4.3. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.4.4. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.4.5. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.4.6. China
    • 8.4.6.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.4.6.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.4.6.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.4.6.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.4.7. Japan
    • 8.4.7.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.4.7.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.4.7.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.4.7.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.4.8. India
    • 8.4.8.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.4.8.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.4.8.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.4.8.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.4.9. South Korea
    • 8.4.9.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.4.9.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.4.9.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.4.9.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.4.10. Australia
    • 8.4.10.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.4.10.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.4.10.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.4.10.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.4.11. Singapore
    • 8.4.11.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.4.11.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.4.11.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.4.11.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
    • 8.5.2. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.5.3. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.5.4. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.5.5. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.5.6. Brazil
    • 8.5.6.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.5.6.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.5.6.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.5.6.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.5.7. Mexico
    • 8.5.7.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.5.7.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.5.7.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.5.7.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
  • 8.6. Middle East & Africa
    • 8.6.1. Market estimates and forecast, by country, 2013 - 2024 (USD Million)
    • 8.6.2. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.6.3. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.6.4. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.6.5. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.6.6. South Africa
    • 8.6.6.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.6.6.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.6.6.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.6.6.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)
    • 8.6.7. UAE
    • 8.6.7.1. Market estimates and forecast, by cell, 2013 - 2024 (USD Million)
    • 8.6.7.2. Market estimates and forecast, by molecule, 2013 - 2024 (USD Million)
    • 8.6.7.3. Market estimates and forecast, by technology, 2013 - 2024 (USD Million)
    • 8.6.7.4. Market estimates and forecast, by end use, 2013 - 2024 (USD Million)

Chapter 9. Company Profiles

  • 9.1. Thermo Fisher Scientific
    • 9.1.1. Business Overview
    • 9.1.2. Financial Data
    • 9.1.3. Product Landscape
    • 9.1.4. Strategic Outlook
  • 9.2. PBS Biotech
    • 9.2.1. Business Overview
    • 9.2.2. Financial Data
    • 9.2.3. Product Landscape
    • 9.2.4. Strategic Outlook
  • 9.3. GE Healthcare
    • 9.3.1. Business Overview
    • 9.3.2. Financial Data
    • 9.3.3. Product Landscape
    • 9.3.4. Strategic Outlook
  • 9.4. Merck Group
    • 9.4.1. Business Overview
    • 9.4.2. Financial Data
    • 9.4.3. Product Landscape
    • 9.4.4. Strategic Outlook
  • 9.5. Cellexus Ltd
    • 9.5.1. Business Overview
    • 9.5.2. Financial Data
    • 9.5.3. Product Landscape
    • 9.5.4. Strategic Outlook
  • 9.6. Pall Corporation
    • 9.6.1. Business Overview
    • 9.6.2. Financial Data
    • 9.6.3. Product Landscape
    • 9.6.4. Strategic Outlook
  • 9.7. Sartorius Stedium Biotech Group
    • 9.7.1. Business Overview
    • 9.7.2. Financial Data
    • 9.7.3. Product Landscape
    • 9.7.4. Strategic Outlook
  • 9.8. Applikon Biotechnology, Inc.
    • 9.8.1. Business Overview
    • 9.8.2. Financial Data
    • 9.8.3. Product Landscape
    • 9.8.4. Strategic Outlook
  • 9.9. GEA Group Aktiengesellschaft
    • 9.9.1. Business Overview
    • 9.9.2. Financial Data
    • 9.9.3. Product Landscape
    • 9.9.4. Strategic Outlook
  • 9.10. BioTron Inc.
    • 9.10.1. Business Overview
    • 9.10.2. Financial Data
    • 9.10.3. Product Landscape
    • 9.10.4. Strategic Outlook
  • 9.11. Bbi Biotech
    • 9.11.1. Business Overview
    • 9.11.2. Financial Data
    • 9.11.3. Product Landscape
    • 9.11.4. Strategic Outlook
  • 9.12. Bailun Bio
    • 9.12.1. Business Overview
    • 9.12.2. Financial Data
    • 9.12.3. Product Landscape
    • 9.12.4. Strategic Outlook
  • 9.13. CerCell
    • 9.13.1. Business Overview
    • 9.13.2. Financial Data
    • 9.13.3. Product Landscape
    • 9.13.4. Strategic Outlook
  • 9.14. Eppendorf
    • 9.14.1. Business Overview
    • 9.14.2. Financial Data
    • 9.14.3. Product Landscape
    • 9.14.4. Strategic Outlook
  • 9.15. Solaris Biotech Solutions
    • 9.15.1. Business Overview
    • 9.15.2. Financial Data
    • 9.15.3. Product Landscape
    • 9.15.4. Strategic Outlook
  • 9.16. Pierre Guerin Technologies
    • 9.16.1. Business Overview
    • 9.16.2. Financial Data
    • 9.16.3. Product Landscape
    • 9.16.4. Strategic Outlook
  • 9.17. CESCO Bioengineering Co. Ltd.
    • 9.17.1. Business Overview
    • 9.17.2. Financial Data
    • 9.17.3. Product Landscape
    • 9.17.4. Strategic Outlook

Data Tables

  • TABLE 1 Bioreactor industry 360 degree synopsis, 2013 - 2024
  • TABLE 2 Global bioreactor market, 2013-2024 (USD Million)
  • TABLE 3 Global bioreactor market, by cell, 2013-2024 (USD Million)
  • TABLE 4 Global bioreactor market, by molecule, 2013-2024 (USD Million)
  • TABLE 5 Global bioreactor market, by technology, 2013-2024 (USD Million)
  • TABLE 6 Global bioreactor market, by end use, 2013-2024 (USD Million)
  • TABLE 7 Global bioreactor market, by region, 2013-2024 (USD Million)
  • TABLE 8 Mammalian cells market, by region, 2013 - 2024 (USD Million)
  • TABLE 9 Bacterial cells market, by region, 2013 - 2024 (USD Million)
  • TABLE 10 Yeast cells market, by region, 2013 - 2024 (USD Million)
  • TABLE 11 Others market, by region, 2013 - 2024 (USD Million)
  • TABLE 12 Monoclonal antibodies market, by region, 2013 - 2024 (USD Million)
  • TABLE 13 Vaccine market, by region, 2013 - 2024 (USD Million)
  • TABLE 14 Recombinant protein market, by region, 2013 - 2024 (USD Million)
  • TABLE 15 Stem cell market, by region, 2013 - 2024 (USD Million)
  • TABLE 16 Gene therapy market, by region, 2013 - 2024 (USD Million)
  • TABLE 17 Other molecules market, by region, 2013 - 2024 (USD Million)
  • TABLE 18 Wave-induced motion SUB market by region, 2013 - 2024 (USD Million)
  • TABLE 19 Stirred SUB market, by region, 2013 - 2024, (USD Million)
  • TABLE 20 Single use bubble column market, by region, 2013 - 2024, (USD Million)
  • TABLE 21 Others market, by region, 2013 - 2024, (USD Million)
  • TABLE 22 R&D market, by region, 2013-2024 (USD Million)
  • TABLE 23 Biopharma manufacturers market, by region, 2013-2024 (USD Million)
  • TABLE 24 Contract manufacturing organisations market, by region, 2013-2024 (USD Million)
  • TABLE 25 North America bioreactor market, by country, 2013 - 2024 (USD Million)
  • TABLE 26 North America bioreactor market, by cell, 2013 - 2024 (USD Million)
  • TABLE 27 North America bioreactor market, by molecule, 2013 - 2024 (USD Million)
  • TABLE 28 North America bioreactor market, by technology, 2013 - 2024 (USD Million)
  • TABLE 29 North America bioreactor market, by end use, 2013 - 2024 (USD Million)
  • TABLE 30 U.S. bioreactor market, by cell, 2013 - 2024 (USD Million)
  • TABLE 31 U.S. bioreactor market, by molecule, 2013 - 2024 (USD Million)
  • TABLE 32 U.S. bioreactor market, by technology, 2013 - 2024 (USD Million)
  • TABLE 33 U.S. bioreactor market, by end use, 2013 - 2024 (USD Million)
  • TABLE 34 Canada bioreactor market, by cell, 2013 - 2024 (USD Million)
  • TABLE 35 Canada bioreactor market, by molecule, 2013 - 2024 (USD Million)
  • TABLE 36 Canada bioreactor market, by technology, 2013 - 2024 (USD Million)
  • TABLE 37 Canada bioreactor market, by end use, 2013 - 2024 (USD Million)
  • TABLE 38 Europe bioreactor market, by country, 2013 - 2024 (USD Million)
  • TABLE 39 Europe bioreactor market, by cell, 2013 - 2024 (USD Million)
  • TABLE 40 Europe bioreactor market, by molecule, 2013 - 2024 (Million)
  • TABLE 41 Europe bioreactor market, by technology, 2013 - 2024 (Million)
  • TABLE 42 Europe bioreactor market, by end use, 2013 - 2024 (Million)
  • TABLE 43 Germany bioreactor market, by cell, 2013 - 2024 (USD Million)
  • TABLE 44 Germany bioreactor market, by molecule, 2013 - 2024 (Million)
  • TABLE 45 Germany bioreactor market, by technology, 2013 - 2024 (Million)
  • TABLE 46 Germany bioreactor market, by end use, 2013 - 2024 (Million)
  • TABLE 47 UK bioreactor market, by cell, 2013 - 2024 (USD Million)
  • TABLE 48 UK bioreactor market, by molecule, 2013 - 2024 (Million)
  • TABLE 49 UK bioreactor market, by technology, 2013 - 2024 (Million)
  • TABLE 50 UK bioreactor market, by end use, 2013 - 2024 (Million)
  • TABLE 51 Spain bioreactor market, by cell, 2013 - 2024 (USD Million)
  • TABLE 52 Spain bioreactor market, by molecule, 2013 - 2024 (Million)
  • TABLE 53 Spain bioreactor market, by technology, 2013 - 2024 (Million)
  • TABLE 54 Spain bioreactor market, by end use, 2013 - 2024 (Million)
  • TABLE 55 Italy bioreactor market, by cell, 2013 - 2024 (USD Million)
  • TABLE 56 Italy bioreactor market, by molecule, 2013 - 2024 (Million)
  • TABLE 57 Italy bioreactor market, by technology, 2013 - 2024 (Million)
  • TABLE 58 Italy bioreactor market, by end use, 2013 - 2024 (Million)
  • TABLE 59 France bioreactor market, by cell, 2013 - 2024 (USD Million)
  • TABLE 60 France bioreactor market, by molecule, 2013 - 2024 (Million)
  • TABLE 61 France bioreactor market, by technology, 2013 - 2024 (Million)
  • TABLE 62 France bioreactor market, by end use, 2013 - 2024 (Million)
  • TABLE 63 Netherlands bioreactor market, by cell, 2013 - 2024 (USD Million)
  • TABLE 64 Netherlands bioreactor market, by molecule, 2013 - 2024 (Million)
  • TABLE 65 Netherlands bioreactor market, by technology, 2013 - 2024 (Million)
  • TABLE 66 Netherlands bioreactor market, by end use, 2013 - 2024 (Million)
  • TABLE 67 Denmark bioreactor market, by cell, 2013 - 2024 (USD Million)
  • TABLE 68 Denmark bioreactor market, by molecule, 2013 - 2024 (Million)
  • TABLE 69 Denmark bioreactor market, by technology, 2013 - 2024 (Million)
  • TABLE 70 Denmark bioreactor market, by end use, 2013 - 2024 (Million)
  • TABLE 71 Asia Pacific bioreactor market, by country, 2013-2024 (USD Million)
  • TABLE 72 Asia Pacific bioreactor market, by cell, 2013-2024 (USD Million)
  • TABLE 73 Asia Pacific bioreactor market, by molecule, 2013-2024 (USD Million)
  • TABLE 74 Asia Pacific bioreactor market, by technology, 2013-2024 (USD million)
  • TABLE 75 Asia Pacific bioreactor market, by end use, 2013-2024 (USD Million)
  • TABLE 76 China bioreactor market, by cell, 2013-2024 (USD Million)
  • TABLE 77 China bioreactor market, by molecule, 2013-2024 (USD Million)
  • TABLE 78 China bioreactor market, by technology, 2013-2024 (USD million)
  • TABLE 79 China bioreactor market, by end use, 2013-2024 (USD Million)
  • TABLE 80 Japan bioreactor market, by cell, 2013-2024 (USD Million)
  • TABLE 81 Japan bioreactor market, by molecule, 2013-2024 (USD Million)
  • TABLE 82 Japan bioreactor market, by technology, 2013-2024 (USD million)
  • TABLE 83 Japan bioreactor market, by end use, 2013-2024 (USD Million)
  • TABLE 84 India bioreactor market, by cell, 2013-2024 (USD Million)
  • TABLE 85 India bioreactor market, by molecule, 2013-2024 (USD Million)
  • TABLE 86 India bioreactor market, by technology, 2013-2024 (USD million)
  • TABLE 87 India bioreactor market, by end use, 2013-2024 (USD Million)
  • TABLE 88 South Korea bioreactor market, by cell, 2013-2024 (USD Million)
  • TABLE 89 South Korea bioreactor market, by molecule, 2013-2024 (USD Million)
  • TABLE 90 South Korea bioreactor market, by technology, 2013-2024 (USD million)
  • TABLE 91 South Korea bioreactor market, by end use, 2013-2024 (USD Million)
  • TABLE 92 Australia bioreactor market, by cell, 2013-2024 (USD Million)
  • TABLE 93 Australia bioreactor market, by molecule, 2013-2024 (USD Million)
  • TABLE 94 Australia bioreactor market, by technology, 2013-2024 (USD million)
  • TABLE 95 Australia bioreactor market, by end use, 2013-2024 (USD Million)
  • TABLE 96 Singapore bioreactor market, by cell, 2013-2024 (USD Million)
  • TABLE 97 Singapore bioreactor market, by molecule, 2013-2024 (USD Million)
  • TABLE 98 Singapore bioreactor market, by technology, 2013-2024 (USD million)
  • TABLE 99 Singapore bioreactor market, by end use, 2013-2024 (USD Million)
  • TABLE 100 Latin America bioreactor market, by country, 2013- 2024, (USD Million)
  • TABLE 101 Latin America bioreactor market, by cell, 2013- 2024, (USD Million)
  • TABLE 102 Latin America bioreactor market, by molecule, 2013 - 2024, (USD Million)
  • TABLE 103 Latin America bioreactor market, by technology, 2013 - 2024, (USD Million)
  • TABLE 104 Latin America bioreactor market, by end-use, 2013 - 2024, (USD Million)
  • TABLE 105 Brazil bioreactor market, by cell, 2013- 2024, (USD Million)
  • TABLE 106 Brazil bioreactor market, by molecule, 2013 - 2024, (USD Million)
  • TABLE 107 Brazil bioreactor market, by technology, 2013 - 2024, (USD Million)
  • TABLE 108 Brazil bioreactor market, by end-use, 2013 - 2024, (USD Million)
  • TABLE 109 Mexico bioreactor market, by cell, 2013- 2024, (USD Million)
  • TABLE 110 Mexico bioreactor market, by molecule, 2013 - 2024, (USD Million)
  • TABLE 111 Mexico bioreactor market, by technology, 2013 - 2024, (USD Million)
  • TABLE 112 Mexico bioreactor market, by end-use, 2013 - 2024, (USD Million)
  • TABLE 113 MEA bioreactor market, by country, 2013- 2024, (USD Million)
  • TABLE 114 MEA bioreactor market, by cell, 2013- 2024, (USD Million)
  • TABLE 115 MEA bioreactor market, by molecule, 2013 - 2024, (USD Million)
  • TABLE 116 MEA bioreactor market, by technology, 2013 - 2024, (USD Million)
  • TABLE 117 MEA bioreactor market, by end-use, 2013 - 2024, (USD Million)
  • TABLE 118 UAE bioreactor market, by cell, 2013- 2024, (USD Million)
  • TABLE 119 UAE bioreactor market, by molecule, 2013 - 2024, (USD Million)
  • TABLE 120 UAE bioreactor market, by technology, 2013 - 2024, (USD Million)
  • TABLE 121 UAE bioreactor market, by end-use, 2013 - 2024, (USD Million)
  • TABLE 122 South Africa bioreactor market, by cell, 2013- 2024, (USD Million)
  • TABLE 123 South Africa bioreactor market, by molecule, 2013 - 2024, (USD Million)
  • TABLE 124 South Africa bioreactor market, by technology, 2013 - 2024, (USD Million)
  • TABLE 125 South Africa bioreactor market, by end-use, 2013 - 2024, (USD Million)

Charts & Figures

  • FIG. 1 Industry segmentation
  • FIG. 2 Global bioreactor market, 2013 - 2024 (USD Million)
  • FIG. 3 Industry ecosystem analysis
  • FIG. 4 Distribution channel analysis
  • FIG. 5 Vendor matrix
  • FIG. 6 Growth potential analysis
  • FIG. 7 Porter's analysis
  • FIG. 8 Competitive landscape, 2014 - 2017
  • FIG. 9 Strategic dashboard
  • FIG. 10 PESTEL analysis
  • FIG. 11 Bioreactor market share by cell, 2016 & 2024
  • FIG. 12 Bioreactor market share by molecule, 2016 & 2024
  • FIG. 13 Bioreactor market share by technology, 2016 & 2024
  • FIG. 14 Bioreactor market share by end-use, 2016 & 2024
  • FIG. 15 Bioreactor market share, by region, 2016 & 2024
Back to Top